Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
Dow
AstraZeneca
Boehringer Ingelheim
Medtronic

Last Updated: November 18, 2019

DrugPatentWatch Database Preview

Hydrocortisone sodium succinate - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic sources for hydrocortisone sodium succinate and what is the scope of freedom to operate?

Hydrocortisone sodium succinate is the generic ingredient in three branded drugs marketed by Abbott, Hospira, Abraxis Pharm, Baxter Hlthcare, Intl Medication, Watson Labs, and Pharmacia And Upjohn, and is included in twenty-five NDAs. Additional information is available in the individual branded drug profile pages.

There are sixty-seven drug master file entries for hydrocortisone sodium succinate. Three suppliers are listed for this compound.

Recent Clinical Trials for hydrocortisone sodium succinate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Emory UniversityPhase 3
The Marcus FoundationPhase 3
Haining Health-Coming Biotech Co., Ltd.Phase 2

See all hydrocortisone sodium succinate clinical trials

Pharmacology for hydrocortisone sodium succinate
Synonyms for hydrocortisone sodium succinate
11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione 21-hemisuccinate sodium salt
125-04-2
2203-97-6 (Parent)
3-{[2-((1S,10S,11S,15S,17S,2R,14R)-14,17-dihydroxy-2,15-dimethyl-5-oxotetracyc lo[8.7.0.0<2,7>.0<11,15>]heptadec-6-en-14-yl)-2-oxoethyl]oxycarbonyl}propanoic acid, sodium salt
50LQB69S1Z
A-hydroCort
A-hydrocort (TN)
AKOS024386298
AKOS032949847
API0002945
Arcocort
Buccalsone
C08178
C25H33O8.Na
CAS-125-04-2
CHEBI:5782
CHEMBL1200495
Corlan
Cortisol 21-(sodium succinate)
Cortisol 21-hemisuccinate sodium
CORTISOL 21-HEMISUCCINATE SODIUM SALT
Cortisol hemisuccinate sodium salt
Cortisol sodium hemisuccinate
Cortisol sodium succinate
Cortisol succinate
Cortisol, 21-(hydrogen succinate), monosodium salt
Cortisol, 21-(hydrogen succinate), monosodium salt (8CI)
CORTISOL, SUCCINATE, SODIUM SALT
Cortop
D00978
DSSTox_CID_28932
DSSTox_GSID_49006
DSSTox_RID_83198
DTXSID2049006
EF-Cortelan soluble
EINECS 204-725-5
Emi-Corlin
EU-0100623
Flebocortid
Flebocortid [inj.]
FT-0627127
H 2270
Hidrokortizon
HMS2234H22
Hycorace
Hydro-Adreson aquosum
Hydrocortisone 21-(sodium succinate)
Hydrocortisone 21-hemisuccinate sodium
Hydrocortisone 21-hemisuccinate sodium salt
Hydrocortisone 21-hemisuccinate sodium salt, >=90% (HPLC)
Hydrocortisone 21-hemisuccinate sodium salt, powder, BioReagent, suitable for cell culture
Hydrocortisone 21-sodium succinate
Hydrocortisone 21-sodium succinide
Hydrocortisone 21-succinate sodium salt
hydrocortisone hemisuccinate
Hydrocortisone hemisuccinate sodium salt
Hydrocortisone sodium 21-hemisuccinate
Hydrocortisone sodium hemisuccinate
Hydrocortisone sodium succinate (JP17/USP)
Hydrocortisone Sodium Succinate [USAN:BAN:JAN]
Hydrocortisone sodium succinate [USP:BAN:JAN]
Hydrocortisone succinate,sodium salt
Hydrocortisone-21-hemisuccinate sodium
Hydrocortisone-21-hemisuccinate sodium salt
Idrocortisone B. I. L
Idrocortisone B. I. L.
Intracort
LS-55001
Lycortin-S
MCULE-7583261760
MFCD00069472
MLS000069545
MolPort-023-278-236
MolPort-044-728-864
NCGC00022248-03
NCGC00022248-04
Nordicort
Nositrol
NSC 9152
Oralsone
Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)-
Q-201213
Rapicort
SCHEMBL93508
SMR000058768
Sodium 17-hydroxycorticosterone 21-succinate
sodium 4-(2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethoxy)-4-oxobutanoate
Sodium hydrocortisone 21-hemisuccinate
Sodium hydrocortisone 21-succinate
Sodium hydrocortisone succinate
sodium;4-[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-4-oxobutanoate
Solu-Cortef
Solu-cortef (TN)
Solu-Glyc
Solu-Hizon
ST51037298
Succinic acid hydrocortisone sodium
Tox21_113501
Tox21_113501_1
U 4905
UNII-50LQB69S1Z

US Patents and Regulatory Information for hydrocortisone sodium succinate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare HYDROCORTISONE SODIUM SUCCINATE hydrocortisone sodium succinate INJECTABLE;INJECTION 087567-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs HYDROCORTISONE SODIUM SUCCINATE hydrocortisone sodium succinate INJECTABLE;INJECTION 084737-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Baxter Hlthcare HYDROCORTISONE SODIUM SUCCINATE hydrocortisone sodium succinate INJECTABLE;INJECTION 086619-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs HYDROCORTISONE SODIUM SUCCINATE hydrocortisone sodium succinate INJECTABLE;INJECTION 084747-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Pharmacia And Upjohn SOLU-CORTEF hydrocortisone sodium succinate INJECTABLE;INJECTION 009866-001 Approved Prior to Jan 1, 1982 RX Yes Yes   Start Trial   Start Trial   Start Trial
Abbott A-HYDROCORT hydrocortisone sodium succinate INJECTABLE;INJECTION 085928-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Hospira A-HYDROCORT hydrocortisone sodium succinate INJECTABLE;INJECTION 085932-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Moodys
McKesson
AstraZeneca
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.